CORRECTION OF IMMUNE ALTERATIONS IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA

The problem of suitable management of the patients with community-acquired pneumonia requires new methods for solving. The conducted examination of the patients with moderate severity communityacquired bacterial pneumonia has showed that assigment of standard therapy did not allow to normalize most of the parameters refl ecting condition of the system complement and cytokines. In the group of patients, where traditional therapy was followed by addition of Derinat, Mexicor and Essentiale Forte H, was a significant decrease of more markers of immune infl ammation. The additional use of immunomodulatory, antioxidant and membrane-protective therapy is immunologically reasonable.